X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12473) 12473
Publication (1514) 1514
Book Review (260) 260
Book Chapter (91) 91
Conference Proceeding (26) 26
Dissertation (5) 5
Data Set (4) 4
Reference (3) 3
Paper (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7210) 7210
index medicus (6756) 6756
animals (4859) 4859
type-2 diabetes-mellitus (4384) 4384
male (3447) 3447
female (2924) 2924
endocrinology & metabolism (2650) 2650
mice (2075) 2075
diabetes (1697) 1697
type-2 (1665) 1665
middle aged (1577) 1577
adult (1419) 1419
insulin resistance (1402) 1402
research (1351) 1351
pharmacology & pharmacy (1348) 1348
risk factors (1321) 1321
biochemistry & molecular biology (1265) 1265
type 2 diabetes (1260) 1260
rats (1216) 1216
obesity (1186) 1186
insulin (1151) 1151
expression (1143) 1143
glucose (1127) 1127
insulin-resistance (1093) 1093
physiological aspects (1080) 1080
aged (1001) 1001
health aspects (999) 999
hypertension (975) 975
immunology (968) 968
inflammation (930) 930
cell biology (886) 886
analysis (863) 863
diabetes mellitus (854) 854
diabetes mellitus, type 2 - drug therapy (834) 834
article (828) 828
medicine, research & experimental (823) 823
peripheral vascular disease (821) 821
metabolic syndrome (813) 813
physiology (785) 785
blood-pressure (747) 747
medicine (735) 735
type-2 diabetic-patients (735) 735
metabolism (715) 715
proteins (710) 710
gene expression (707) 707
cardiac & cardiovascular systems (693) 693
oxidative stress (673) 673
genetic aspects (670) 670
multidisciplinary sciences (657) 657
research article (654) 654
review (648) 648
signal transduction (646) 646
receptor (645) 645
type-2 receptor (643) 643
mice, inbred c57bl (634) 634
rodents (600) 600
hypoglycemic agents - therapeutic use (598) 598
abridged index medicus (596) 596
glucagon-like peptide-1 (594) 594
care and treatment (591) 591
gene-expression (587) 587
blood glucose - metabolism (567) 567
medicine, general & internal (561) 561
risk (560) 560
in-vivo (558) 558
neurosciences (558) 558
cells, cultured (549) 549
cardiovascular disease (534) 534
urology & nephrology (506) 506
ii type-2 receptor (504) 504
insulin - metabolism (497) 497
studies (496) 496
disease models, animal (491) 491
disease (489) 489
glycemic control (484) 484
activation (477) 477
treatment outcome (473) 473
atherosclerosis (471) 471
genetics & heredity (471) 471
cardiovascular-disease (461) 461
dextrose (458) 458
angiotensin (457) 457
double-blind (456) 456
cells (455) 455
cell line (454) 454
mutation (454) 454
apoptosis (448) 448
science (448) 448
internal medicine (445) 445
renin-angiotensin system (445) 445
hypoglycemic agents - pharmacology (428) 428
biology (424) 424
blood pressure (424) 424
mice, knockout (422) 422
medicine & public health (420) 420
cytokines (419) 419
nutrition & dietetics (415) 415
cardiovascular diseases (403) 403
coronary-artery-disease (402) 402
adipose-tissue (397) 397
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12353) 12353
German (42) 42
French (37) 37
Spanish (32) 32
Russian (13) 13
Polish (10) 10
Japanese (8) 8
Hungarian (4) 4
Chinese (3) 3
Portuguese (2) 2
Czech (1) 1
Dutch (1) 1
Italian (1) 1
Korean (1) 1
Turkish (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunity, ISSN 1074-7613, 2010, Volume 33, Issue 5, pp. 736 - 751
Journal Article
Philosophical Transactions: Biological Sciences, ISSN 0962-8436, 12/2012, Volume 367, Issue 1607, pp. 3216 - 3228
The endocannabinoid system was revealed following the understanding of the mechanism of action of marijuana's major psychotropic principle,... 
Enzymes | Receptors | Cannabinoids | Neuroscience | Neurons | Agonists | Ligands | Biosynthesis | Endocannabinoids | Cannabinoid receptors | Transient receptor potential vanilloid type-1 | Cannabinoid receptor type-1 | Cannabinoid receptor type-2 | Endocannabinoid | Cannabinoid | Endovanilloid | endovanilloid | endocannabinoid | cannabinoid | transient receptor potential vanilloid type-1 | cannabinoid receptor type-1 | cannabinoid receptor type-2 | NERVE GROWTH-FACTOR | CB1 RECEPTOR | VANILLOID TYPE-1 RECEPTORS | ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL | CALCIUM-CHANNELS | ACID AMIDE HYDROLASE | LONG-TERM DEPRESSION | BIOLOGY | SMOOTH-MUSCLE-CELLS | PRIMARY SENSORY NEURONS | TRPV1 CHANNELS | Endocannabinoids - metabolism | Cannabinoid Receptor Agonists - metabolism | Endocannabinoids - pharmacology | Receptor, Cannabinoid, CB2 - agonists | Humans | Cannabinoid Receptor Agonists - pharmacology | Synaptic Transmission | Brain - metabolism | TRPV Cation Channels - metabolism | Arachidonic Acids - metabolism | Pain Perception - drug effects | Receptor, Cannabinoid, CB1 - agonists | TRPV Cation Channels - antagonists & inhibitors | Neuralgia - physiopathology | Receptor Cross-Talk | Signal Transduction | Glycerides - metabolism | Polyunsaturated Alkamides - metabolism | Arachidonic Acids - pharmacology | Neuralgia - drug therapy | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Glycerides - pharmacology | Animals | Polyunsaturated Alkamides - pharmacology | 133 | 202 | Review
Journal Article
Journal Article
Nature, ISSN 0028-0836, 04/2017, Volume 544, Issue 7650, pp. 327 - 332
Journal Article
Circulation, ISSN 0009-7322, 04/2008, Volume 117, Issue 17, pp. 2253 - 2261
Background - In obesity, decreases in adiponectin and increases in proinflammatory adipokines are associated with heart disease. Because adipocytes express... 
Obesity | Adipose tissue | Mineralocorticoid receptor | Diabetes mellitus | Inflammation | Aldosterone | Aldosterone antagonists | MACROPHAGE INFILTRATION | METABOLIC SYNDROME | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | aldosterone | adipose tissue | diabetes mellitus | mineralocorticoid receptor | inflammation | INSULIN-RESISTANCE | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | aldosterone antagonists | HEMATOLOGY | TYPE-2 DIABETES-MELLITUS | TRANSCRIPTIONAL REGULATION | obesity | ADIPOSE-TISSUE | Diabetes Mellitus, Experimental - drug therapy | Body Weight | Myocardium - immunology | Obesity - drug therapy | Obesity - immunology | Receptors, Mineralocorticoid - metabolism | Male | PPAR gamma - immunology | Adipose Tissue - immunology | RNA, Messenger - metabolism | Inflammation - complications | Inflammation - drug therapy | Mice, Mutant Strains | Adipokines - genetics | Adiponectin - genetics | Diabetes Mellitus, Experimental - complications | Leptin - immunology | Mineralocorticoid Receptor Antagonists | PPAR gamma - genetics | Obesity - complications | Homeostasis - immunology | Aldosterone - pharmacology | Adipokines - immunology | Inflammation - immunology | Leptin - genetics | 3T3-L1 Cells | Diabetes Mellitus, Experimental - immunology | Animals | Triglycerides - blood | Biomarkers | Mice | Adiponectin - immunology | Adipose Tissue - drug effects
Journal Article
by Cho, JH and Oh, AY and Park, S and Kang, SM and Yoon, MH and Woo, TG and Hong, SD and Hwang, J and Ha, NC and Lee, HY and Park, BJ
MOLECULAR CANCER THERAPEUTICS, ISSN 1535-7163, 11/2018, Volume 17, Issue 11, pp. 2271 - 2284
Neurofibromatosis type 2 (NF2) syndrome is a very rare human genetic disease, and there has been no proper treatment for it until now, In our recent study, it... 
K-RAS | ONCOLOGY | PROSTATE-CANCER CELLS | P53 SUPPRESSION | PHASE-II | SCHWANN-CELLS | LARGE GENE LISTS | NEUROFIBROMATOSIS TYPE-2 | MALIGNANT MESOTHELIOMA | CHOLESTEROL-BIOSYNTHESIS | OCCUPATIONAL-EXPOSURE
Journal Article